Amanote Research

Amanote Research

    RegisterSign In

Preclinical Evidence of Ghrelin as a Therapeutic Target in Epilepsy

Oncotarget - United States
doi 10.18632/oncotarget.18349
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

June 2, 2017

Authors
Tongtong GeWei YangJie FanBingjin Li
Publisher

Impact Journals, LLC


Related search

H-Channels as a Therapeutic Target in Epilepsy

Epilepsy Currents
Neurology
2003English

Preclinical Rationale for TGF-β Inhibition as a Therapeutic Target for the Treatment of Myelofibrosis

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2016English

Lysosomes as a Therapeutic Target

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2019English

CD38 as a Therapeutic Target

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2006English

Is Mossy Fiber Sprouting a Potential Therapeutic Target for Epilepsy?

Frontiers in Neurology
Neurology
2018English

Tax as a Therapeutic Target in ATL

Retrovirology
VirologyInfectious Diseases
2015English

Inflammation as a Therapeutic Target in Atherosclerosis

Journal of Clinical Medicine
2019English

Candida Albicansdimorphism as a Therapeutic Target

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2012English

Tumor Evolution as a Therapeutic Target

Cancer Discovery
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy